China’s Akeso gets share boost as data shows cancer drug’s benefits

www.scmp.com

China’s Akeso gets share boost as data shows cancer drug’s benefits

www.scmp.com

rssMB to

Left News WireEnglish · 2 days ago

Lung-cancer drug ivonescimab is ‘potentially two to three years ahead of competitors’, analyst says.

From China - South China Morning Post via this RSS feed

You must log in or # to comment.

Chat

Left News Wire

lefty_news

Create a post

You are not logged in. However you can subscribe from another Fediverse account, for example Lemmy or Mastodon. To do this, paste the following into the search field of your instance: !lefty_news@ibbit.at

A leftist newswire providing commentary, opinion, and covering current events of the rapidly changing political and geopolitical economic landscape.

Visibility: Public

This community can be federated to other instances and be posted/commented in by their users.

353 users / day
1.62K users / week
2.76K users / month
3.6K users / 6 months
1 local subscriber
274 subscribers
10.7K Posts
1.46K Comments
Modlog